Back to search
Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder trials you may qualify forThis phase II trial tests how well tafasitamab and rituximab work for front-line treatment of patients with post-transplant lymphoproliferative disorder. Post-t…
This phase Ib trial tests the safety and effectiveness of epcoritamab in treating patients with post-transplant lymphoproliferative disorder (PTLD) that has com…